Tata India Pharma & Healthcare Fund Regular-Growth - Returns, Rating & Analysis | Ionic Wealth
Tata India Pharma & Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.45% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic AI
Loading...
Fund Overview
Rating
2
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹1326 Cr
Created on
1 Dec 2015
Fund Ranking
#12
/ 14 in Sectoral-Pharma
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
1.2%
1 Year
5.8%
3 Year (CAGR)
21.6%
All Time (CAGR)
11.4%
Category Return
6 Month
4.9%
1 Year
10.6%
3 Year (CAGR)
23.0%
All Time (CAGR)
-
Asset Allocation
Equity
99.6%
Other
0.4%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
4.06%
Aurobindo Pharma
0.70%
Bayer CropScience
3.34%
Cipla
5.07%
Coromandel International
1.17%
Fund Information
Expense Ratio
3.27%
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Lock-In Period
No Lock-In
Managed By
Meeta Shetty
Nov 2018 - Present
Rajat Srivastava
Sep 2024 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.94
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
17.10
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
-2.76
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.